Literature DB >> 11165953

Bone mineral metabolism after total gastrectomy.

J T Heiskanen1, H Kröger, M Pääkkönen, M T Parviainen, C Lamberg-Allardt, E Alhava.   

Abstract

Gastric surgery is mostly needed for treatment of gastric malignancy. To investigate the effect of total gastrectomy on bone mineral density (BMD) and bone mineral metabolism we evaluated 18 patients after total gastrectomy. Mean interval since operation was 71 +/- 20 months. BMD results were compared with age- and gender-matched controls (n = 46) and also expressed as T and Z scores. Bone mineral density measured by dual-energy X-ray absorptiometry (DXA) was found to be significantly lower in patients after total gastrectomy compared with healthy controls in the lumbar spine (p = 0.017 for women, p = 0.002 for men), femoral neck (p = 0.004 for women, p = 0.001 for men), Ward's triangle (p = 0.031 for women, p = 0.003 for men), and greater trochanter (p = 0.001 for women, p = 0.001 for men). Z scores for lumbar spine, femoral neck, Ward's triangle, and greater trochanter were -0.83, -1.54, -1.02, and -1.19, respectively. Biochemical measurements correlated poorly with BMD and were found to be of lesser value in diagnosing reduced bone mass as well as in differential diagnosis of etiology of osteopenia. The results of our study show the deleterious effect of total gastrectomy on bone mineral status and suggest an increased fracture risk in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11165953     DOI: 10.1016/s8756-3282(00)00404-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Authors:  M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

2.  Effects of total gastrectomy on plasma silicon and amino acid concentrations in men.

Authors:  Marcin R Tatara; Witold Krupski; Maria Szpetnar; Andrzej Dąbrowski; Paweł Bury; Anna Szabelska; Anna Charuta; Anna Boguszewska-Czubara; Ryszard Maciejewski; Grzegorz Wallner
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-02

Review 3.  The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.

Authors:  J Keller; T Schinke
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

4.  The change of bone mineral density and bone metabolism after gastrectomy for gastric cancer: a meta-analysis.

Authors:  H J Oh; B-H Yoon; Y-C Ha; D-C Suh; S-M Lee; K-H Koo; Y-K Lee
Journal:  Osteoporos Int       Date:  2019-11-27       Impact factor: 4.507

5.  Risk of osteoporosis after gastrectomy in long-term gastric cancer survivors.

Authors:  Seung Hyun Yoo; Jung Ah Lee; Seo Young Kang; Young Sik Kim; Sung Sunwoo; Beom Soo Kim; Jeong-Hwan Yook
Journal:  Gastric Cancer       Date:  2017-11-21       Impact factor: 7.370

Review 6.  Osteopenia and osteoporosis in gastrointestinal diseases: diagnosis and treatment.

Authors:  J C Southerland; J F Valentine
Journal:  Curr Gastroenterol Rep       Date:  2001-10

7.  High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy.

Authors:  Jung Sub Lim; Sang Bum Kim; Ho-Yoon Bang; Gi Jeong Cheon; Jong-Inn Lee
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

8.  Chronic gastritis and bone mineral density in women.

Authors:  Adriana M Kakehasi; Carolinne B Rodrigues; Ariane V Carvalho; Alfredo J A Barbosa
Journal:  Dig Dis Sci       Date:  2008-08-07       Impact factor: 3.199

Review 9.  Skeletal sequelae of cancer and cancer treatment.

Authors:  Charles J Stava; Camilo Jimenez; Mimi I Hu; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2009-05-02       Impact factor: 4.442

10.  Mineral metabolism in obese patients following vertical banded gastroplasty.

Authors:  José M Olmos; Luis A Vázquez; José A Amado; José L Hernández; Jesús González Macías
Journal:  Obes Surg       Date:  2008-01-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.